Buy Granules India Ltd. at a price target of Rs 122.0 and a stoploss at Rs 112 from entry point.

Buy Granules India Ltd. at a price target of Rs 100.0 and a stoploss at Rs 89 from entry point.

Buy Granules India Ltd. at a price target of Rs 110.0 and a stoploss at Rs 94 from entry point.

Buy Granules India Ltd. at a price target of Rs 106.0 and a stoploss at Rs 94 from entry point.

Buy Granules India Ltd. at a price target of Rs 100.0 and a stoploss at Rs 92 from entry point.

Buy Granules India Ltd. at a price target of Rs 100 and a stoploss at Rs 88 from entry point.

Sell Granules India Ltd. at a price target of Rs 75 and a stoploss at Rs 86 from entry point.

Buy Granules India Ltd. at a price target of Rs 116.0 and a stop loss at Rs 107.5 from the entry point.

Buy Granules India Ltd. at a price target of Rs 140.0 and a stop loss at Rs 128 from entry point.

Buy Granules India at a price target of Rs 128 and a stop loss at Rs 117 from entry point.

Buy Granules India at a price target of Rs 140 and a stop loss at Rs 130 from entry point.

Buy Granules India at a price target of Rs 138 and a stop loss at Rs 130 from entry point.

Buy Granules India Ltd. at a price target of Rs 160.0 and a stop loss at Rs 149.0 from entry point

The key body responsible for settling corporate disputes has told Zenotech Laboratories that it cannot reappoint two board members without ...

The Company Law Board (CLB) on Thursday stopped Hyderabad-based Zenotech Laboratories from holding its board meeting on Friday.

Ranbaxy told the Company Law Board that Zenotech's founder MD Jayaram Chigurupati has no right to appoint the directors as he was attemptin...

Ranbaxy Laboratories has objected to the appointment of two new directors to the board of Zenotech Laboratories, continuing a battle of att...